Back to Journals » Neuropsychiatric Disease and Treatment » Volume 14

New horizons for multiple sclerosis therapeutics: milestones in the development of ocrelizumab

Total article views   HTML views PDF downloads Totals
13,405 Dovepress* 10,885+ 1,774 12,659
PubMed Central* 2,520 844 3,364
Totals 13,405 2,618 16,023
*Since 23 April 2018
Total mentioned Facebook Delicious Reddit Twitter Others
4 1 0 0 1 2

View citations on PubMed Central and Google Scholar